Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap.

Weinberg GA, Szilagyi PG.

J Infect Dis. 2010 Jun 1;201(11):1607-10. doi: 10.1086/652404. No abstract available.

2.

Accelerating HIV vaccine development.

Koff WC.

Nature. 2010 Mar 11;464(7286):161-2. doi: 10.1038/464161a. No abstract available.

PMID:
20220821
3.

Mathematical modelling of effectiveness.

McLean AR.

Dev Biol Stand. 1998;95:225-33.

PMID:
9855436
4.

11th Annual Conference on Vaccine Research.

O'Brien J.

Expert Rev Vaccines. 2008 Aug;7(6):721-3. doi: 10.1586/14760584.7.6.721.

PMID:
18665770
5.

Vaccine immunology.

Bartlett BL, Pellicane AJ, Tyring SK.

Dermatol Ther. 2009 Mar-Apr;22(2):104-9. doi: 10.1111/j.1529-8019.2009.01223.x. Review.

PMID:
19335722
6.

Vaccines. Overview.

Rabinovich NR, Orenstein WA.

Epidemiol Rev. 1999;21(1):1-6. Review.

7.

A review of the effectiveness of vaccine potency control testing.

McVey DS, Galvin JE, Olson SC.

Int J Parasitol. 2003 May;33(5-6):507-16. Review.

PMID:
12782051
8.

Human vaccine research in the European Union.

Olesen OF, Lonnroth A, Mulligan B.

Vaccine. 2009 Jan 29;27(5):640-5. doi: 10.1016/j.vaccine.2008.11.064. Epub 2008 Dec 6. Review.

PMID:
19059446
9.

Genetics, aging population challenge vaccine researchers.

Lavine G.

Am J Health Syst Pharm. 2008 Jun 1;65(11):996, 998-9. doi: 10.2146/news080044. No abstract available.

PMID:
18499866
10.

Translational models for studying meniscal repair and replacement: what they can and cannot tell us.

Arnoczky SP, Cook JL, Carter T, Turner AS.

Tissue Eng Part B Rev. 2010 Feb;16(1):31-9. doi: 10.1089/ten.TEB.2009.0428. Review.

PMID:
19698055
11.

New approaches in vaccine development.

Leclerc C.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):329-41. Review.

PMID:
12818620
12.

Vaccine-induced immunologic memory and pace of pathogenesis: predicting the need for boosters.

Pichichero ME.

Expert Rev Vaccines. 2008 Nov;7(9):1299-303. doi: 10.1586/14760584.7.9.1299. No abstract available.

PMID:
18980532
13.

Novel vaccines: bridging research, development and production.

Demirjian A, Levy O.

Expert Rev Vaccines. 2008 Nov;7(9):1321-4. doi: 10.1586/14760584.7.9.1321.

PMID:
18980535
14.

Age-related decline in immunity: implications for vaccine responsiveness.

Kumar R, Burns EA.

Expert Rev Vaccines. 2008 May;7(4):467-79. doi: 10.1586/14760584.7.4.467. Review.

PMID:
18444893
15.

Infectious diseases know no borders: a plea for more collaboration between researchers in human and veterinary vaccines.

Van der Zeijst BA.

Vet J. 2008 Oct;178(1):1-2. doi: 10.1016/j.tvjl.2008.02.023. Epub 2008 Apr 11. No abstract available.

PMID:
18406639
16.

5th Annual Conference of the Organisation of Oncology and Translational Research. Foreword.

Gl├╝ck S.

Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S1-2. doi: 10.1517/13543781003748582. No abstract available.

PMID:
20374020
17.

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities.

Schuchat A, Bell BP.

Expert Rev Vaccines. 2008 May;7(4):437-56. doi: 10.1586/14760584.7.4.437. Review.

PMID:
18444891
18.

Moving toward a three-way intersection in translational research: a sociological perspective.

van den Hoonaard DK.

Qual Health Res. 2009 Dec;19(12):1783-7. doi: 10.1177/1049732309354998.

PMID:
19949226
19.
20.

From clinical research to vaccination policy: 25 years experience in vaccinology.

Hessel L.

Hum Vaccin. 2009 Mar;5(3):114-8. Epub 2009 Mar 5. No abstract available.

PMID:
19229131
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk